2018 annual financial data
Aldeyra Therapeutics 2018 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -39,699,000 USD and net income was -38,893,000 USD.
Operating cash flow was -29,857,131 USD.
Get free Aldeyra Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -39,699,000 USD
- Net income
- -38,893,000 USD
- Operating cash flow
- -29,857,131 USD